enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tenecteplase - Wikipedia

    en.wikipedia.org/wiki/Tenecteplase

    Tenecteplase, sold under the trade names TNKase, Metalyse and Elaxim, is an enzyme used as a thrombolytic drug.. Tenecteplase is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established mammalian cell line (Chinese hamster ovary cells).

  3. Tissue-type plasminogen activator - Wikipedia

    en.wikipedia.org/wiki/Tissue-type_plasminogen...

    FDA-approved for treatment of myocardial infarction with ST-elevation (STEMI), acute ischemic stroke (AIS), acute massive pulmonary embolism, and central venous access devices (CVAD). [28] Reteplase: FDA-approved for acute myocardial infarction, where it has more convenient administration and faster thrombolysis than alteplase. This is because ...

  4. Cerebroprotectant - Wikipedia

    en.wikipedia.org/wiki/Cerebroprotectant

    A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.

  5. ELIQUIS® (apixaban) Approved In Japan For The ... - AOL

    www.aol.com/news/2012-12-26-eliquis-apixaban...

    ELIQUIS ® (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol ...

  6. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  7. Canadian Stroke Network - Wikipedia

    en.wikipedia.org/wiki/Canadian_Stroke_Network

    The Ontario Stroke Registry (formerly the Registry of the Canadian Stroke Network (RCSN)) was established in 2001 to allow for the measurement and monitoring of stroke care delivery and outcomes in Canadian patients at participating institutions, and to serve as a rich clinical database for investigator-initiated research projects.

  8. It's Time to Stop Believing These Common Menopause Myths - AOL

    www.aol.com/time-stop-believing-common-menopause...

    Case in point: Estrogen reduces your risk of developing an osteoporotic hip fracture by as much as 50 percent. “If you stop taking HRT, your bones age rapidly. “If you stop taking HRT, your ...

  9. Insomnia: What Exactly Is It & How Do I Treat It? - AOL

    www.aol.com/insomnia-exactly-treat-125700471.html

    It can also increase your risk of developing a whole host of medical problems, including weight gain, high blood pressure, heart disease, diabetes, a weakened immune system, and accelerated aging ...

  1. Related searches is tnk approved for stroke risk care

    is tnk approved for stroke risk care plan